Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells

Int J Mol Sci. 2020 Sep 16;21(18):6811. doi: 10.3390/ijms21186811.

Abstract

Drug resistance of childhood cancer neuroblastoma is a serious clinical problem. Patients with relapsed disease have a poor prognosis despite intense treatment. In the present study, we aimed to identify chemoresistance gene expression signatures in vincristine resistant neuroblastoma cells. We found that vincristine-resistant neuroblastoma cells formed larger clones and survived under reduced serum conditions as compared with non-resistant parental cells. To identify the possible mechanisms underlying vincristine resistance in neuroblastoma cells, we investigated the expression profiles of genes known to be involved in cancer drug resistance. This specific gene expression patterns could predict the behavior of a tumor in response to chemotherapy and for predicting the prognosis of high-risk neuroblastoma patients. Our signature could help chemoresistant neuroblastoma patients in avoiding useless and harmful chemotherapy cycles.

Keywords: chemoresistance; neuroblastoma; vincristine.

Publication types

  • Comparative Study

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cisplatin / pharmacology
  • Clone Cells
  • Drug Resistance, Neoplasm / genetics*
  • Etoposide / pharmacology
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics
  • Neuroblastoma / drug therapy
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Nocodazole / pharmacology
  • Prognosis
  • Transcriptome*
  • Vincristine / pharmacology*
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Neoplasm Proteins
  • Vincristine
  • Etoposide
  • Cisplatin
  • Nocodazole